Navigation Links
Drug Repurposing, Rescue, and Repositioning: A groundbreaking new journal from Mary Ann Liebert, Inc.
Date:12/11/2013

New Rochelle, NY, December 11, 2013Mary Ann Liebert, Inc., publishers is pleased to announce Drug Repurposing, Rescue, and Repositioning, a dynamic new peer-reviewed journal that will present techniques and tools for finding new uses for approved drugsparticularly for disorders where no animal model, physiologic abnormality, biochemical pathway, or molecular target has been identified. The Journal will be published online with open access options and in print, and is currently under the leadership of Managing Editor Bill Ferguson, PhD.

Repurposing allows human investigation early in the drug discovery process, speeding up the development of important therapeutics. Repurposing can be an important tool in dissecting complex disorders, discovering molecular targets, and unraveling disease processes leading to therapeutic compounds for drug discovery and development. Drug "rescue" refers to research using small molecules and biologics that previously were used in studies but not further developed and submitted for Food and Drug Administration (FDA) approval. Drug repositioning is a scientifically logical process for finding new uses for drugs in well-defined and selected patient populations. These initiatives have attracted the attention of regulators around the world; the National Institutes of Health in the United States has launched its National Center for Advancing Translational Medicine (NCATS), with the goal of promoting drug repurposing by industry. There are also several similar European and Asian initiatives already well underway.

Drug Repurposing, Rescue, and Repositioning will include original papers, application-oriented technology reviews, and reports in methodology and technology application. Timely and authoritative articles will cover topics such as: assay design, target development, high-throughput technologies, and chemistry; lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis; approaches to assays configured for gene families, inherited, and infectious diseases; assays and strategies for adapting model organisms to drug discovery; the use of stem cells as models of disease; translation of phenotypic outputs to target identification; and exploration and mechanistic studies of the technical basis for assay and screening artifacts.


'/>"/>

Contact: Bill Ferguson
bferguson@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Related biology news :

1. Lawson recieves Grand Challenges Explorations grant for groundbreaking research
2. Groundbreaking discovery of the cellular origin of cervical cancer
3. Groundbreaking discovery of mechanism that controls obesity, atherosclerosis
4. UCLA Receives $46 Thousand Check for Groundbreaking Research on Debilitating Pregnancy Disease
5. Soft Robotics: A groundbreaking new journal on engineered soft devices that Interact with Living Systems
6. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
7. MSU launches groundbreaking drug trial in Africa
8. DNA SPECTRUM LAUNCHES GROUNDBREAKING DNA STORAGE PRODUCT
9. Canadian researchers lead groundbreaking discovery in deadly childhood cancer
10. Tips from the journal mBio
11. Canadian Journal of Cardiology publishes new atrial fibrillation guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/22/2016)... , June 22, 2016   Acuant ... and verification solutions, has partnered with RightCrowd ... solutions for Visitor Management, Self-Service Kiosks and ... products that add functional enhancements to existing ... corporations and venues with an automated ID ...
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... project, for the , Supply and Delivery of ... Infrastructure , to Decatur , ... Management Solutions. Numerous renowned international vendors participated in the tendering ... selected for the most compliant and innovative solution. The contract ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... June 23, 2016  The Prostate Cancer Foundation (PCF) is pleased ... and faster cures for prostate cancer. Members of the Class of 2016 were ... Read More About the Class of 2016 PCF Young ... ... ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... ... ... STACS DNA Inc., the sample tracking software company, today announced that Dr. ... STACS DNA as a Field Application Specialist. , “I am thrilled that Dr. ... STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings a ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology: